SEER Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

1.705

Open

1.670

VWAP

1.68

Vol

454.67K

Mkt Cap

92.37M

Low

1.670

Amount

766.11K

EV/EBITDA(TTM)

--

Total Shares

54.98M

EV

-73.75M

EV/OCF(TTM)

--

P/S(TTM)

--

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.

Show More

Events Timeline

(ET)

2026-05-14

08:10:00

Radoff and Torok Propose to Acquire Seer for $2.40 per Share

2026-05-13 (ET)

2026-05-13

07:40:00

Seer Sues Nanomics Biotechnology for Patent Infringement

2026-05-04 (ET)

2026-05-04

07:30:00

Seer Appoints Anthony Bazarko as Chief Commercial Officer

2026-04-29 (ET)

2026-04-29

08:10:00

Radoff-JEC Group's $2.35 Per Share Acquisition Proposal for Seer Rejected

2026-04-27 (ET)

2026-04-27

07:40:00

Seer Board Unanimously Rejects Acquisition Proposal

2026-04-24 (ET)

2026-04-24

07:10:00

Radoff-JEC Group Proposes to Acquire Seer for $2.35 per Share

2026-04-13 (ET)

2026-04-13

14:00:00

Seer Receives Acquisition Proposal at $2.25 per Share

2026-04-13

08:10:00

Radoff-JEC Proposes to Acquire Seer for $2.25 per Share

2026-03-30 (ET)

2026-03-30

07:20:00

Seer Secures Patent Review Support for Nanoparticle Technology

News

seekingalpha

05-14seekingalpha

Seer Acquisition Offer Raised to $2.40 per Share

seekingalpha

05-13seekingalpha

Seer, Inc. Q1 2026 Earnings Call Insights

seekingalpha

05-13seekingalpha

Seer Files Patent Infringement Lawsuit Against Nanomics

moomoo

SEER INC: CANACCORD GENUITY BEGINS COVERAGE WITH A BUY RATING AND A TARGET PRICE OF $4

CNBC

Latest Wall Street Rating Updates

Yahoo Finance

04-29Yahoo Finance

Shareholders Lose Trust in CEO and Board's Value Creation

Valuation Metrics

The current forward P/E ratio for Seer Inc (SEER.O) is 0.00, compared to its 5-year average forward P/E of -5.98. For a more detailed relative valuation and DCF analysis to assess Seer Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-5.98

Current PE

0.00

Overvalued PE

2.25

Undervalued PE

-14.22

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-2.21

Current EV/EBITDA

-0.55

Overvalued EV/EBITDA

4.86

Undervalued EV/EBITDA

-9.28

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

42.48

Current PS

4.44

Overvalued PS

122.09

Undervalued PS

-37.13

Financials

AI Analysis

Annual

Quarterly

Whales Holding SEER

SoftBank Group Corp.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Seer Inc (SEER) stock price today?

The current price of SEER is 1.68 USD — it has decreased -0.59

What is Seer Inc (SEER)'s business?

Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.

What is the price predicton of SEER Stock?

Wall Street analysts forecast SEER stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SEER is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Seer Inc (SEER)'s revenue for the last quarter?

Seer Inc revenue for the last quarter amounts to 2.79M USD, decreased -33.58

What is Seer Inc (SEER)'s earnings per share (EPS) for the last quarter?

Seer Inc. EPS for the last quarter amounts to USD, decreased -100.00

How many employees does Seer Inc (SEER). have?

Seer Inc (SEER) has 124 emplpoyees as of May 20 2026.

What is Seer Inc (SEER) market cap?

Today SEER has the market capitalization of 92.37M USD.